Discovery and reporting of clinically-relevant germline variants in advanced cancer patients assessed using whole-exome sequencing is a research paper. On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5T32GM007739-30
Weill Cornell/Rockefeller/Sloan-Kettering MST Program
National Institutes of Health
Grant: 5R01CA194547-03
The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma
Fields of Study
Sustainable Development Goals